{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/haemorrhoids/prescribing-information/topical-haemorrhoidal-preparations/","result":{"pageContext":{"chapter":{"id":"5e73660e-f8bd-59f1-bb81-7421d6528421","slug":"topical-haemorrhoidal-preparations","fullItemName":"Topical haemorrhoidal preparations","depth":2,"htmlHeader":"<!-- begin field b0ad5ad9-770f-44cd-a047-e8f8559742c8 --><h2>Topical haemorrhoidal preparations</h2><!-- end field b0ad5ad9-770f-44cd-a047-e8f8559742c8 -->","summary":"","htmlStringContent":"<!-- begin item 019513d1-4ac6-4dab-b8e4-25b8d373d05e --><!-- end item 019513d1-4ac6-4dab-b8e4-25b8d373d05e -->","topic":{"id":"f7906562-4fee-5a84-8303-379c1264e3a1","topicId":"602684c2-aefe-47f4-8cd4-a073fae976fd","topicName":"Haemorrhoids","slug":"haemorrhoids","lastRevised":"Last revised in December 2016","chapters":[{"id":"9349c3d4-585b-5a5c-9330-84732a59d51d","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"52331225-5fe4-5e5c-93e3-001e75392b51","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"c45a7da5-46fd-508b-9e45-f98e7d939a1d","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"b1223559-471e-54d8-8c83-8189eb61fc94","slug":"changes","fullItemName":"Changes"},{"id":"e821eb1c-58f1-534b-a58c-3b9052710878","slug":"update","fullItemName":"Update"}]},{"id":"1244c725-1653-55ce-8c72-e37d3ac00ba8","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"38a8aa2e-e227-570e-b068-d52250cc56b1","slug":"goals","fullItemName":"Goals"},{"id":"9654ebf6-8b46-59c9-943d-7896c69c2423","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"9ee0ecc3-8f67-5568-805d-353603370077","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"ff46554d-bfca-5cf3-b619-6a90336a5343","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"ca98b89f-4318-5536-b43e-3494d38d695c","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"17333caf-01c0-5404-9647-f2d9ebab9385","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"121915e0-bf27-5b91-bb04-bf683bfe09ca","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"38911d73-2ec8-510e-8d1a-7d132e2fbbb6","slug":"definition","fullItemName":"Definition"},{"id":"16285996-ae00-5a0b-ae75-a2e3fbe1b61b","slug":"prevalence","fullItemName":"Prevalence"},{"id":"64018a1c-fa5e-5916-86be-85aae7e0f363","slug":"complications","fullItemName":"Complications"},{"id":"d8cf0430-fe9d-5917-b258-daf3338ae098","slug":"prognosis","fullItemName":"Prognosis"},{"id":"34029121-830e-53d1-8c6c-7b28f4480c21","slug":"predisposing-factors","fullItemName":"Predisposing factors"}]},{"id":"83208acd-70e2-5631-bb6d-6940476c6550","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"99806532-3c83-5b1e-a348-dd3e57ecc5db","slug":"diagnosis","fullItemName":"Diagnosis"},{"id":"584224f2-e8ca-5dac-a5c4-36d0f26327b4","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"3afaad49-aa40-5b38-bc45-4810a36b8027","fullItemName":"Management","slug":"management","subChapters":[{"id":"0c01f78e-7814-5eca-8432-46ef1a8232f9","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"a945ef3f-12e3-5d72-8763-24c126ba2c38","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"5e73660e-f8bd-59f1-bb81-7421d6528421","slug":"topical-haemorrhoidal-preparations","fullItemName":"Topical haemorrhoidal preparations"}]},{"id":"7934db00-cccc-5131-a549-a42c8066ae81","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"786063e1-af46-5584-bf01-44a63d55f6cd","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"da4df504-1c23-5730-b56a-3d259ed346eb","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"376b046c-d9fa-5bd5-a9dd-0feb5ee61c2b","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"f3593aa4-5cf3-58eb-8ccc-86cb2a10a70b","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"81ece68e-d376-5f04-bbce-c8ecf08a282f","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"a29796b5-b0ad-556e-8cf2-3d174119c86b","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"3903523b-faab-5f5c-b657-2d17e77f0cf4","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"a945ef3f-12e3-5d72-8763-24c126ba2c38","slug":"prescribing-information","fullItemName":"Prescribing information"},"subChapters":[{"id":"281bb32f-6dd7-590a-8029-53b1f09cce32","slug":"choice-of-topical-preparations","fullItemName":"Choice of topical preparations","depth":3,"htmlHeader":"<!-- begin field 1ab2e42b-9b97-44ba-af45-55dfb6a2711b --><h3>Which topical haemorrhoidal preparations are available and which should I prescribe?</h3><!-- end field 1ab2e42b-9b97-44ba-af45-55dfb6a2711b -->","summary":"","htmlStringContent":"<!-- begin item 5c0b4f01-c06d-4c1e-aa7d-094de7afc04d --><!-- begin field c275d7f5-625f-493a-936a-ac40979cac1a --><ul><li><strong>Haemorrhoidal preparations usually contain multiple ingredients, </strong>including astringent, lubricants, antiseptic, local anaesthetic, and/or corticosteroids. <ul><li>There is no evidence that any topical haemorrhoidal preparations is more effective than another. The choice of preparation should therefore be based on the risk of adverse effects and the person's symptoms and preference.<ul><li>Preparations containing mild astringents or lubricants relieve local irritation and are less likely to cause skin sensitization.</li><li>Preparations containing local anaesthetics may alleviate pain, burning, and itching, but can cause sensitization of the anal skin. Lidocaine is the preferred topical anaesthetic because others, including tetracaine, cinchocaine (dibucaine), and pramocaine (pramoxine), are more irritant.</li><li>Preparations containing corticosteroids may reduce inflammation and pain, but prolonged use may lead to skin atrophy, contact dermatitis, and skin sensitization. Local infection (for example herpes simplex infection or perianal thrush) must be excluded before use.</li></ul></li></ul></li><li><strong>Haemorrhoidal preparations are available over-the-counter or on prescription, and include creams and ointments (generally used for external haemorrhoids) and s</strong><strong>uppositories (generally used for internal haemorrhoids).</strong><ul><li>Examples of proprietary topical haemorrhoidal preparations available in the UK are listed below. A complete list of the available haemorrhoidal preparations are available in the British National Formulary (BNF) [<a class=\"bibliography-reference internal-reference\" href=\"/topics/haemorrhoids/references/\">BNF 71, 2016</a>]:<ul><li>Anusol<sup>®</sup> cream/ointment/suppositories: contains astringent(s) and an emollient.</li><li>Anacal<sup>®</sup> rectal ointment/suppositories: contains a heparinoid.</li><li>Anodesyn<sup>®</sup> ointment/suppositories: contains a local anaesthetic (lidocaine).</li><li>Germoloids<sup>®</sup> cream/ointment/suppositories: contains a local anaesthetic (lidocaine) and astringent(s).</li><li>Anusol HC Plus<sup>®</sup>/Anusol HC<sup>®</sup> ointment/suppositories: contains a corticosteroid (hydrocortisone acetate) and astringent(s).</li><li>Proctosedyl<sup>®</sup> ointment/suppositories: contains a local anaesthetic (cinchocaine) and a corticosteroid (hydrocortisone).</li><li>Anugesic-HC<sup>®</sup> cream/suppositories: contains a local anaesthetic (pramocaine), a corticosteroid (hydrocortisone acetate), and an astringent.</li></ul></li><li><strong>No topical haemorrhoidal preparations are licensed for use during pregnancy or breastfeeding. </strong>However, the potential risk of harms to the pregnant woman and/or fetus is likely to be less with simple, soothing products than with those containing corticosteroid and/or local anaesthetic (which are generally not recommended by the manufacturers for use during pregnancy due to inadequate safety evidence). </li><li><strong>For </strong><strong>detailed information on the different haemorrhoidal preparations, </strong>see the manufacturer's Summary of Product Characteristics (SPC, available on <a data-hyperlink-id=\"c3d3f37d-9c62-4f92-8771-a992011e58cb\" href=\"https://www.medicines.org.uk/emc/\">www.medicines.org.uk/emc</a>).</li></ul></li><li><strong>If a topical haemorrhoidal preparation is prescribed or recommended, </strong>advise the person on the <a class=\"topic-reference internal-reference\" href=\"/topics/haemorrhoids/prescribing-information/topical-haemorrhoidal-preparations/#information-advice\">safe use</a> of the preparation.</li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/haemorrhoids/references/\">BNF 71, 2016</a>]</p><!-- end field c275d7f5-625f-493a-936a-ac40979cac1a --><!-- end item 5c0b4f01-c06d-4c1e-aa7d-094de7afc04d -->","subChapters":[]},{"id":"deda6e37-aeb8-5eea-a9a8-8b8d810a68f3","slug":"information-advice","fullItemName":"Information and advice","depth":3,"htmlHeader":"<!-- begin field 6311a010-9b4a-42f0-b232-1d60b6af4ef8 --><h3>What should I advise on the safe use of topical haemorrhoidal preparations?</h3><!-- end field 6311a010-9b4a-42f0-b232-1d60b6af4ef8 -->","summary":"","htmlStringContent":"<!-- begin item 91d77802-32aa-42da-981a-40553c222f26 --><!-- begin field 7fdbd6c9-911a-4148-b1ad-a5738ddec17a --><ul><li><strong>If a topical haemorrhoidal preparation is prescribed or recommended, a</strong><strong>dvise the person:</strong><ul><li>On how to use it:<ul><li>Generally, haemorrhoidal preparation should be used in the morning and night, and after a bowel movement. See the manufacturer's Summary of Product Characteristics (SPC) of the recommended product (available on <a href=\"https://www.medicines.org.uk/emc/\" data-hyperlink-id=\"9709c57e-e7d4-4afd-b4cd-a98f00f29ac0\">www.medicines.org.uk/emc</a>) for detailed information on how to use the product. </li><li>Anaesthetic-containing preparations should only be used for a few days because they may cause sensitization of the anal skin.</li><li>Corticosteroid-containing preparations should be used for no longer than 7 days because prolonged use may lead to skin atrophy, contact dermatitis, and skin sensitization. Excessive application should be avoided, as systematic absorption can occur through the rectal mucosa. </li></ul></li><li>That local adverse effects may occur on application, such as burning, erythema, exfoliation, or irritation (frequency unknown).  </li><li>That they should seek advice from a pharmacist before buying over-the-counter topical haemorrhoidal preparations as they may contain similar ingredients to the one prescribed (including corticosteroid and/or local anaesthetic). </li></ul></li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/haemorrhoids/references/\">BNF 71, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/haemorrhoids/references/\">ABPI, 2016</a>]</p><!-- end field 7fdbd6c9-911a-4148-b1ad-a5738ddec17a --><!-- end item 91d77802-32aa-42da-981a-40553c222f26 -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}